634.14
전일 마감가:
$661.00
열려 있는:
$662.45
하루 거래량:
830.53K
Relative Volume:
0.96
시가총액:
$72.26B
수익:
$14.20B
순이익/손실:
$4.41B
주가수익비율:
16.57
EPS:
38.28
순현금흐름:
$3.54B
1주 성능:
-4.63%
1개월 성능:
-12.35%
6개월 성능:
-38.50%
1년 성능:
-34.02%
리제네론 파마슈티컬스 Stock (REGN) Company Profile
명칭
Regeneron Pharmaceuticals Inc
전화
(914) 847-7000
주소
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
REGN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
REGN
Regeneron Pharmaceuticals Inc
|
634.14 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
509.04 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
ARGX
Argen X Se Adr
|
605.52 | 36.93B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
280.96 | 36.37B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
250.47 | 27.23B | 3.81B | -644.79M | -669.77M | -6.24 |
리제네론 파마슈티컬스 Stock (REGN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2025-01-16 | 다운그레이드 | UBS | Buy → Neutral |
2024-12-10 | 재개 | BofA Securities | Underperform |
2024-11-15 | 개시 | Wolfe Research | Outperform |
2024-11-14 | 개시 | Citigroup | Neutral |
2024-09-24 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
2024-03-12 | 개시 | Bernstein | Outperform |
2024-01-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2023-11-09 | 개시 | Deutsche Bank | Hold |
2023-11-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2023-08-21 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2023-08-21 | 재확인 | Oppenheimer | Perform |
2023-06-28 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2023-03-27 | 업그레이드 | SVB Securities | Market Perform → Outperform |
2023-03-24 | 업그레이드 | Jefferies | Hold → Buy |
2023-03-23 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
2023-01-30 | 업그레이드 | Cowen | Market Perform → Outperform |
2023-01-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
2022-10-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
2022-10-17 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2022-09-09 | 업그레이드 | Jefferies | Underperform → Hold |
2022-09-09 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2022-07-25 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2022-07-13 | 개시 | Cantor Fitzgerald | Neutral |
2022-06-06 | 개시 | Jefferies | Underperform |
2022-05-23 | 개시 | SVB Leerink | Outperform |
2022-01-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-01-03 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
2021-12-15 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
2021-12-09 | 재개 | Wells Fargo | Overweight |
2021-12-07 | 재개 | Cowen | Market Perform |
2021-12-06 | 개시 | Goldman | Buy |
2021-11-19 | 재개 | BMO Capital Markets | Outperform |
2021-11-05 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2021-06-29 | 개시 | H.C. Wainwright | Buy |
2021-01-25 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2021-01-13 | 업그레이드 | The Benchmark Company | Hold → Buy |
2021-01-08 | 업그레이드 | Citigroup | Neutral → Buy |
2020-10-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2020-08-20 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2020-07-09 | 업그레이드 | SunTrust | Hold → Buy |
2020-05-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2020-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
2020-04-17 | 업그레이드 | The Benchmark Company | Hold → Buy |
2020-04-08 | 개시 | The Benchmark Company | Hold |
2020-03-31 | 개시 | Wolfe Research | Peer Perform |
2020-02-27 | 개시 | Barclays | Overweight |
2020-02-26 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2020-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
2020-02-25 | 업그레이드 | Jefferies | Hold → Buy |
2020-02-11 | 업그레이드 | Argus | Hold → Buy |
2019-12-24 | 개시 | Raymond James | Mkt Perform |
2019-12-16 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2019-12-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
2019-11-12 | 개시 | SunTrust | Hold |
2019-11-07 | 업그레이드 | Citigroup | Neutral → Buy |
2019-10-17 | 재개 | BofA/Merrill | Neutral |
2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
모두보기
리제네론 파마슈티컬스 주식(REGN)의 최신 뉴스
Is Regeneron Pharmaceuticals, Inc. (REGN) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance
Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MSN
Regeneron to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2025 - The Manila Times
Regeneron Earnings Alert: Key Q1 2025 Results Coming April 29What to Watch - StockTitan
Regeneron stock touches 52-week low at $641.91 amid market shifts By Investing.com - Investing.com South Africa
Regeneron stock touches 52-week low at $641.91 amid market shifts - Investing.com
Regeneron's Franchise Tax Claims Require Trial, NY Judge Rules - Bloomberg Tax
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst? - Insider Monkey
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Corebridge Financial Inc. - MarketBeat
Vanguard Group Inc. Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Lawsuit Notice: Investors who hold Regeneron - GlobeNewswire
11 Best Extremely Profitable Stocks to Buy According to Analysts - Insider Monkey
Nerve Growth Factor Market: Analysis of Epidemiology, Pipeline - openPR
Opthea Phase 3 Trial Fails To Meet Primary Endpoint, Faces Financial Uncertainty - Benzinga
Simplify Asset Management Inc. Lowers Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Short Interest Update - MarketBeat
KLP Kapitalforvaltning AS Makes New $34.47 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
AXQ Capital LP Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Mizuho Securities USA LLC - MarketBeat
Xponance Inc. Has $11.59 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
DCF Advisers LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Harvest Fund Management Co. Ltd Buys 1,366 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Corient Private Wealth LLC Trims Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Forefront Wealth Management Inc. Acquires New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
American Century Companies Inc. Sells 30,949 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Virtu Financial LLC Has $3.06 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Summit Global Investments - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Teacher Retirement System of Texas - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Madison Investment Advisors LLC Makes New $4.59 Million Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Avantax Advisory Services Inc. Boosts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Royal London Asset Management Ltd. - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Increased by Envestnet Portfolio Solutions Inc. - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Decreases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Advisors Asset Management Inc. Sells 443 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
iA Global Asset Management Inc. Decreases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Commonwealth Equity Services LLC Sells 967 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
11,358 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Acquired by Generali Asset Management SPA SGR - MarketBeat
Nikko Asset Management Americas Inc. Sells 2,730 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Genmab, NHS England, Pistoia Alliance and Regeneron Win Bio-IT World Innovative Practices Awards - PR Newswire
First Week of November 21st Options Trading For Regeneron Pharmaceuticals (REGN) - Nasdaq
Blueshift Asset Management LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Vinva Investment Management Ltd Buys 1,182 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
3 Reasons to Sell REGN and 1 Stock to Buy Instead - Financial Content
Short Interest in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Increases By 16.8% - Defense World
Cibc World Markets Corp Grows Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Age-Related Macular Degeneration Therapeutics Market - openPR
Natixis Advisors LLC Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Kazazian Asset Management LLC Invests $399,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Thrivent Financial for Lutherans Has $89.18 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Intact Investment Management Inc. Acquires Shares of 500 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
리제네론 파마슈티컬스 (REGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
리제네론 파마슈티컬스 주식 (REGN) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
McCourt Marion | EVP Commercial |
Nov 01 '24 |
Option Exercise |
381.40 |
1,000 |
381,400 |
13,931 |
McCourt Marion | EVP Commercial |
Nov 01 '24 |
Sale |
844.61 |
1,000 |
844,610 |
12,931 |
자본화:
|
볼륨(24시간):